Erratum to: Perioperative High-Dose-Rate Brachytherapy in the Treatment of Recurrent Malignant Gliomas
β Scribed by Maria Grazia Fabrini; Franco Perrone; Lucia De Franco; Francesco Pasqualetti; Silvia Grespi; Riccardo Vannozzi; Luca Cionini
- Publisher
- Springer
- Year
- 2009
- Tongue
- German
- Weight
- 166 KB
- Volume
- 185
- Category
- Article
- ISSN
- 0179-7158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. Recurrent head and neck malignancies are therapeutically challenging. Brachytherapy is a retreatment alternative to external-beam radiation therapy (EBRT). Methods. Patients receiving brachytherapy during 1987-2004 for recurrent head and neck cancer were identified. Tumor and treatment
Seventeen patients less than or equal to 20 years of age with newly diagnosed (n = 10) or recurrent (n = 7) malignant gliomas (anaplastic astrocytoma and glioblastoma multiforme) were treated with cyclophosphamide in association with hematopoietic cytokines (GM-CSF or G-CSF). Cyclophosphamide was gi